Eicarg Finance

Only Business & Financial News


icon

Zantac's link to cancer being explored in court hitting pharma stocks

In 2019, the drug was reviewed for a probable carcinogen. More than 2,000 cases have been filed claiming Zantac can generate the carcinogen. Many pharma companies are implicated because the drug is off patent.
CNBC
2022-08-12 10:39:52